Home LiteratureArticle Details
PMID: 7542635 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Glycosphingolipids from Sphingomonas paucimobilis induce monokine production in human mononuclear cells.

Infection and immunity ·Vol. 63 ·No. 8 ·1995-08-00 ·Pages 2899-905

Krziwon C, Zähringer U, Kawahara K, Weidemann B, Kusumoto S, Rietschel ET, Flad HD, Ulmer AJ

Abstract

Glycosphingolipids (GSL) isolated from the gram-negative lipopolysaccharide (LPS)-free bacterium Sphingomonas paucimobilis have remarkable structural similarities with LPS and its hydrophobic part, termed lipid A. Like LPS, but in contrast to the structurally related ceramides and cerebrosides, GSL contain an alpha-linked, negatively charged pyranosidic glycosyl component adjacent to the lipid portion and are capable of forming membranes. Because of these similarities, it was of interest to investigate whether these GSL are also able to induce monokine production in human mononuclear cells (MNC). Our results show that a GSL containing four sugar residues (GSL-4A) induced the release of tumor necrosis factor, interleukin-6, and interleukin-1 in MNC, whereas GSL-1, containing only one glycosyl residue, was inactive. A minimal concentration of 1 microgram of GSL-4A per ml was necessary to induce monokine production in MNC, whereas LPS was as active at a 10,000-fold-lower concentration (0.1 ng/ml). Both GSL-4A-induced monokine production and LPS-induced monokine production were reduced by the bactericidal/permeability-increasing protein and GSL-1. In contrast to LPS, GSL-4A-induced monokine release could be inhibited neither by an anti-CD14 monoclonal antibody nor by lipid A partial structures. We therefore conclude that at the receptor level, different mechanisms are involved in the LPS- and GSL-4A-induced monokine release.

MeSH Terms
Antigens, CD/physiology Antigens, Differentiation, Myelomonocytic/physiology Antimicrobial Cationic Peptides Blood Proteins/pharmacology Glycosphingolipids/chemistry,immunology Glycosylation Gram-Negative Bacteria/chemistry,immunology Humans In Vitro Techniques Interleukin-1/biosynthesis Interleukin-6/biosynthesis Leukocytes, Mononuclear/immunology,metabolism Lipid A/chemistry,immunology Lipopolysaccharide Receptors Lipopolysaccharides/chemistry,pharmacology Membrane Proteins Structure-Activity Relationship Tumor Necrosis Factor-alpha/biosynthesis
Chemicals
Antigens, CD Antigens, Differentiation, Myelomonocytic Antimicrobial Cationic Peptides Blood Proteins Glycosphingolipids Interleukin-1 Interleukin-6 Lipid A Lipopolysaccharide Receptors Lipopolysaccharides Membrane Proteins Tumor Necrosis Factor-alpha bactericidal permeability increasing protein
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Krziwon C
Department of Immunology and Cell Biology, Forschungsinstitut Borstel, Germany.
Zähringer U
Kawahara K
Weidemann B
Kusumoto S
Rietschel E T
Flad H D
Ulmer A J
References (42)
42 references, click to expand
  1. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells.
    J Biol Chem. 1994 Jul 1;269(26):17606-10 PMID: 8021269
  2. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation.
    J Biol Chem. 1994 Jul 1;269(26):17411-6 PMID: 7517398
  3. Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides.
    Adv Carbohydr Chem Biochem. 1994;50:211-76 PMID: 7942255
  4. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.
    Scand J Clin Lab Invest Suppl. 1968;97:77-89 PMID: 4179068
  5. A new method for the extraction of R lipopolysaccharides.
    Eur J Biochem. 1969 Jun;9(2):245-9 PMID: 5804498
  6. Isolation of a novel sphingoglycolipid containing glucuronic acid and 2-hydroxy fatty acid from Flavobacterium devorans ATCC 10829.
    J Biochem. 1978 Apr;83(4):1213-6 PMID: 659393
  7. Bacterial endotoxins and host immune responses.
    Adv Immunol. 1979;28:293-450 PMID: 396770
  8. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.
    J Exp Med. 1986 Sep 1;164(3):777-93 PMID: 2427635
  9. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen.
    Eur J Immunol. 1986 Dec;16(12):1583-9 PMID: 3493149
  10. Production of hybridoma growth factor by human monocytes.
    Eur J Immunol. 1987 Oct;17(10):1411-6 PMID: 3500054
  11. Biology of interleukin 1.
    FASEB J. 1988 Feb;2(2):108-15 PMID: 3277884
  12. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage.
    J Immunol. 1988 Jul 15;141(2):547-52 PMID: 3385210
  13. IL-1 induction-capacity of defined lipopolysaccharide partial structures.
    J Immunol. 1989 May 1;142(9):3229-38 PMID: 2651523
  14. The role of cachectin/TNF in endotoxic shock and cachexia.
    Immunol Today. 1988 Jan;9(1):28-31 PMID: 3076757
  15. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14.
    Mol Immunol. 1989 Jul;26(7):657-62 PMID: 2779588
  16. Detection of interleukin 1 with human dermal fibroblasts.
    Immunobiology. 1989 Jun;179(2-3):283-91 PMID: 2477329
  17. Induction of tumor necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures.
    Immunobiology. 1989 Oct;179(4-5):293-307 PMID: 2613271
  18. Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo.
    J Exp Med. 1990 Jul 1;172(1):77-84 PMID: 2193101
  19. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).
    FASEB J. 1990 Aug;4(11):2860-7 PMID: 2199284
  20. Structure and function of lipopolysaccharide binding protein.
    Science. 1990 Sep 21;249(4975):1429-31 PMID: 2402637
  21. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
    Science. 1990 Sep 21;249(4975):1431-3 PMID: 1698311
  22. Suppressive effect of lipid A partial structures on lipopolysaccharide or lipid A-induced release of interleukin 1 by human monocytes.
    FEMS Microbiol Immunol. 1990 Oct;2(3):179-85 PMID: 2257173
  23. Molecular modelling of bacterial deep rough mutant lipopolysaccharide of Escherichia coli.
    Eur J Biochem. 1991 May 8;197(3):707-16 PMID: 2029900
  24. Multiple receptors for endotoxin.
    Curr Opin Immunol. 1991 Feb;3(1):83-90 PMID: 1711327
  25. Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells.
    Infect Immun. 1991 Dec;59(12):4655-64 PMID: 1937825
  26. Chemical structure of glycosphingolipids isolated from Sphingomonas paucimobilis.
    FEBS Lett. 1991 Nov 4;292(1-2):107-10 PMID: 1959589
  27. Gangliosides suppress tumor necrosis factor production in human monocytes.
    J Immunol. 1992 Mar 15;148(6):1753-8 PMID: 1371788
  28. Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A.
    FEMS Microbiol Immunol. 1992 Jan;4(2):73-89 PMID: 1547025
  29. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS.
    J Immunol. 1992 Jul 1;149(1):200-6 PMID: 1607653
  30. Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures.
    Infect Immun. 1992 Aug;60(8):3309-14 PMID: 1639498
  31. Bacterial endotoxins.
    Sci Am. 1992 Aug;267(2):54-61 PMID: 1641625
  32. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
    J Exp Med. 1992 Aug 1;176(2):485-94 PMID: 1380063
  33. Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes.
    J Exp Med. 1992 Sep 1;176(3):719-27 PMID: 1380975
  34. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.
    Infect Immun. 1992 Nov;60(11):4754-61 PMID: 1398985
  35. Recognition of bacterial endotoxins by receptor-dependent mechanisms.
    Adv Immunol. 1993;53:267-89 PMID: 7685560
  36. Phase behavior, supramolecular structure, and molecular conformation of lipopolysaccharide.
    Immunobiology. 1993 Apr;187(3-5):191-211 PMID: 8330897
  37. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Immunobiology. 1993 Apr;187(3-5):417-29 PMID: 8330906
  38. Activation of human monocytes and granulocytes by monoclonal antibodies to glycosylphosphatidylinositol-anchored antigens.
    Eur J Immunol. 1993 Nov;23(11):2782-91 PMID: 8223854
  39. Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9930-4 PMID: 7694296
  40. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
    J Exp Med. 1994 Jan 1;179(1):269-77 PMID: 7505800
  41. Bacterial endotoxin: molecular relationships of structure to activity and function.
    FASEB J. 1994 Feb;8(2):217-25 PMID: 8119492
  42. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures.
    Infect Immun. 1994 Nov;62(11):4709-15 PMID: 7523297
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1995-08-00
Pages
2899-905
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC173394
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com